Godavari Drugs

Godavari Drugs EBIT per Share

The EBIT per Share of Godavari Drugs (530317.BO) as of Oct 17, 2026 is 8.42 INR. In the previous year, EBIT per Share was 9.26 INR — a change of -9.12% (lower).

EBIT per Share

8.42INR

YoY

-9.12%

Last updated:

EBIT per Share of Godavari Drugs is 2026 8.42 INR. EBIT per Share of Godavari Drugs was 2025 9.26 INR. It decreases by -9.12% lower compared to the previous year.

The Godavari Drugs EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
4.34 INR
Jan 1, 2020
4.81 INR
Jan 1, 2021
8.50 INR
Jan 1, 2022
9.47 INR
Jan 1, 2023
8.10 INR
Jan 1, 2024
11.69 INR
Jan 1, 2025
9.26 INR
Jan 1, 2026
8.42 INR
The Godavari Drugs EBIT per Share history
YEAREBIT per ShareYoY
8.42INR-9.12%
9.26INR-20.75%
11.69INR+44.23%
8.10INR-14.46%
9.47INR+11.50%
8.50INR+76.58%
4.81INR+10.97%
4.34INR+43.73%
3.02INR-48.55%
5.86INR+14.11%
5.14INR+1.95%
5.04INR+542.11%
0.78INR+3.27%
0.76INR-138.51%
-1.97INR-2,566.67%
0.08INR-166.67%
-0.12INR-59.09%
-0.29INR-70.67%
-1.00INR-22.58%
-1.29INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Godavari Drugs Stock analysis

What does Godavari Drugs do? Godavari Drugs Ltd, based in Secunderabad, Telangana, manufactures active pharmaceutical ingredients (APIs) and intermediates for the global life science industry. The company operates facilities in Nanded, Maharashtra, producing APIs such as Ciprofloxacin HCl and Mefenamic Acid, along with intermediates like A D Lactone and 6 Mercaptopurine. It partners with multinational firms through contract manufacturing and holds active loan licenses for API production. Godavari Drugs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Godavari Drugs stock

EBIT per Share of Godavari Drugs is 8.42 INR in 2026.

EBIT per Share of Godavari Drugs changed from 9.26 INR to 8.42 INR, representing a -9.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Godavari Drugs since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Godavari Drugs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Godavari Drugs